Early MCI Detection Without Adding Staff Time in LTC

For Directors of Nursing and Medical Directors in long-term care, maintaining resident well-being while managing staff workloads is a constant challenge. Consider the statistic: 12 million Americans are living with Mild Cognitive Impairment (MCI) [citation needed], and 92% are unaware of their condition [citation needed]. This highlights a critical gap in early detection, hindering timely intervention and care planning. What if there was a way to achieve **early MCI detection without adding staff time**? Scienza Health offers a approach that addresses this challenge head-on, using advanced technology to screen for cognitive decline with minimal disruption to your team's clinical process. This offers a proactive approach to resident care, ensuring those at risk receive the support they need.

The Silent Epidemic: Understanding Mild Cognitive Impairment

Mild Cognitive Impairment (MCI) represents a transitional state between normal age-related cognitive changes and dementia. While not all individuals with MCI progress to dementia, it significantly increases the risk. Identifying MCI early is important because it allows for interventions like lifestyle modifications, cognitive therapies, and medication management, potentially slowing down the progression of cognitive decline. However, the challenge lies in effectively screening for MCI without placing undue burden on already stretched staff. Traditional cognitive assessments can be time-consuming and require specialized training, making widespread screening impractical in many long-term care settings. This is where an automated, staff-free approach becomes invaluable. The ability to identify at-risk residents early can dramatically improve their quality of life and potentially reduce the long-term costs associated with more advanced cognitive impairment. With GIA, you can begin to address this issue proactively and efficiently.

GIA: Automated Cognitive Screening Without Staff Involvement

Scienza Health's GIA offers a revolutionary approach to cognitive screening in long-term care. GIA is a sophisticated speech-based assessment platform that screens for cognitive decline with 70.8% accuracy. What sets GIA apart is its ability to conduct these screenings without requiring direct staff involvement. Residents interact with GIA through Samsung Health Grade Galaxy devices with Samsung Knox, answering simple questions or completing basic tasks. The entire process takes under 5 minutes, and results are available within 60 seconds. GIA uses over 2,500 speech biomarkers to detect subtle changes in cognitive function that may be indicative of MCI. This automated approach eliminates the need for staff to administer and score cognitive tests, freeing up their time to focus on direct resident care. Moreover, GIA is HIPAA compliant, ensuring the privacy and security of resident data. Explore how GIA integrates with PointClickCare to simplify your clinical process.

How GIA Works: A Simple and Efficient Process

Implementing GIA in your long-term care facility is straightforward. Residents can use Samsung Health Grade Galaxy devices with Samsung Knox to interact with GIA. GIA speaks 92 languages, ensuring accessibility for a diverse resident population. The platform guides residents through a series of cognitive assessments, including ADLs and IADLs, capturing speech data in the background. This data is then analyzed to identify patterns and indicators of cognitive decline. The results are presented in an easy-to-understand format, highlighting potential areas of concern. Furthermore, GIA integrates directly with leading EHR systems like PointClickCare, Epic, Cerner, and MatrixCare, allowing for automated data transfer and streamlined documentation. The ADL and IADL results are written back to the EHR for a complete resident picture. This integration minimizes manual data entry and ensures that cognitive screening results are readily available to the care team. GIA is a screening tool and does not diagnose; a human-in-the-loop approach is always maintained.

The Financial Benefits of Early Detection

Beyond improving resident care, implementing early MCI detection strategies can also offer significant financial benefits for long-term care facilities. By identifying residents at risk of cognitive decline early, facilities can implement targeted interventions to slow the progression of the disease and potentially reduce the need for more intensive and costly care in the future. Furthermore, GIA supports billing through established CPT codes, including 96127 ($6-10), 96116 ($94-131), and 99309 (~$100), providing a clear pathway for reimbursement. Addressing cognitive decline also helps facilities adhere to CMS F-Tag 758, which focuses on providing appropriate care and services to maintain or improve each resident's functional abilities. By proactively addressing cognitive decline, facilities can demonstrate a commitment to quality care and improve their overall performance ratings. Consider a clinical deployment program to see how GIA can impact your bottom line.

Accuracy and Reliability: The Science Behind GIA

Scienza Health is committed to providing accurate and reliable cognitive screening approaches. GIA has been rigorously tested and validated, demonstrating a high degree of accuracy in detecting cognitive decline. Specifically, GIA achieves 70.8% accuracy in cognitive decline detection. For Parkinson's screening, GIA achieves an AUC of 0.97. These results are based on extensive clinical data and sophisticated algorithms that analyze speech patterns and other biomarkers. It's important to remember that GIA is a screening tool, not a diagnostic tool. While GIA can identify individuals who may be at risk of cognitive decline, further evaluation by a qualified healthcare professional is necessary to confirm a diagnosis and develop an appropriate treatment plan. The human-in-the-loop approach ensures clinical oversight and responsible use of this technology. Remember that GIA also screens for Depression (81.6% accuracy), PTSD (80.0%), and Anxiety (77.5%).

Implementing GIA: A Step Towards Proactive Care

Integrating GIA into your long-term care facility is a strategic investment in the well-being of your residents and the efficiency of your staff. By automating cognitive screening, you can identify individuals at risk of MCI early, enabling timely interventions and improved care planning. GIA's direct integration with existing EHR systems and its ability to be administered without staff involvement makes it a practical and cost-effective approach for long-term care facilities of all sizes. Take the first step towards proactive care by exploring how GIA can transform your approach to cognitive health. With 46 conditions screened (21 live, 25 coming soon) and over 2,500 speech biomarkers analyzed, GIA is a powerful tool for improving resident outcomes and optimizing staff resources. Let's discuss how a demo of GIA can benefit your organization.

Conclusion

Early detection of Mild Cognitive Impairment is important for improving resident outcomes and optimizing care planning in long-term care facilities. Scienza Health's GIA offers a unique approach that enables **early MCI detection without adding staff time**, using advanced technology to screen for cognitive decline with minimal disruption to your team's clinical process. With 12 million Americans living with MCI and 92% unaware, the need for proactive screening has never been greater. Take the first step towards improving resident care and optimizing staff resources by requesting a demo of GIA today. See how our 510(k) registered, HIPAA compliant approach can transform your approach to cognitive health.